![Jörg W. Menten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jörg W. Menten
No open positions remaining
Profile
Jörg W.
Menten served as the Chief Executive Officer & Managing Director at SphingoTec GmbH from 2022 to 2024.
Prior to that, he was the Co-Chairman-Supervisory Board & CFO at Vanguard AG from 2009 to 2011.
From 2001 to 2007, he held the position of President-KCI International at Kinetic Concepts, Inc. Mr. Menten obtained an MBA from the University of Mannheim.
Former positions of Jörg W. Menten
| Companies | Position | End |
|---|---|---|
SphingoTec GmbH
 SphingoTec GmbH BiotechnologyHealth Technology Develops method for prediction, prevention, intervention of cancer, cardiovascular disease and kidney function | Chief Executive Officer | 25/03/2024 |
Vanguard AG
 Vanguard AG Miscellaneous Commercial ServicesCommercial Services Specializes in process optimization of medical devices | Chairman | 23/11/2011 |
Kinetic Concepts, Inc.
 Kinetic Concepts, Inc. Medical SpecialtiesHealth Technology Develops advanced wound care solutions and therapies | Corporate Officer/Principal | 29/04/2007 |
Training of Jörg W. Menten
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
24
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Kinetic Concepts, Inc.
Kinetic Concepts, Inc. Medical SpecialtiesHealth Technology Develops advanced wound care solutions and therapies | Health Technology |
University of Mannheim
 University of Mannheim Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vanguard AG
Vanguard AG Miscellaneous Commercial ServicesCommercial Services Specializes in process optimization of medical devices | Commercial Services |
SphingoTec GmbH
SphingoTec GmbH BiotechnologyHealth Technology Develops method for prediction, prevention, intervention of cancer, cardiovascular disease and kidney function | Health Technology |
- Stock Market
- Insiders
- Jörg W. Menten
